William Kilgo, MD

Director of the neurology residency program and assistant professor of neurology at the University of South Alabama College of Medicine.

Articles by William Kilgo, MD

Collateral Damage to Patients From Formulary Restrictions in Multiple Sclerosis: Perspectives from an MS Specialist, a Patient, and a Neurologist in Training

ByWilliam Kilgo, MD

July 22nd 2025

Navigating insurance hurdles for multiple sclerosis treatments poses significant risks, as seen in a patient's devastating relapse after denied care.

Reviewing the Utilization of Serum Biomarker Tests for Diagnosing Multiple Sclerosis: William Kilgo, MD

ByWilliam Kilgo, MD

October 16th 2023

The director of the neurology residency program and assistant professor of neurology at the University of South Alabama College of Medicine shared his insights from a year’s worth of using a serum biomarker test for the diagnosis of multiple sclerosis. [WATCH TIME: 5 minutes]

Latest Updated Articles

Collateral Damage to Patients From Formulary Restrictions in Multiple Sclerosis: Perspectives from an MS Specialist, a Patient, and a Neurologist in Training
Published: July 22nd 2025 | Updated:

William Kilgo, MD

Articles by William Kilgo, MD

Collateral Damage to Patients From Formulary Restrictions in Multiple Sclerosis: Perspectives from an MS Specialist, a Patient, and a Neurologist in Training

Reviewing the Utilization of Serum Biomarker Tests for Diagnosing Multiple Sclerosis: William Kilgo, MD

Latest Updated Articles

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

Newly Unveiled EPIC Trial Pins Myasthenia Gravis Medications Nipocalimab Against Efgartigimod for Efficacy

Efgartigimod Effective in Seronegative gMG, Obexelimab Meets Primary End Point, FDA Accepts NDA for Tau Tracer MK-6240

Efgartigimod Treatment for CIDP Leads to Increased Spending, Study Shows

AI in MS: IJMSC Survey Results

NeurologyLive® Friday 5 — October 31, 2025